WHITE PAPER
Proteomic associations across neuropsychiatric conditions: Novel insights from the UK Biobank
Explore UK Biobank insights into the proteome of neuropsychiatric diseases
What can the circulating proteome reveal about shared and distinct biology across neuropsychiatric conditions?
This White Paper explores large-scale UK Biobank proteomic data (generated through the Olink Explore research platform) across neurodegenerative, neurological, psychiatric, and addiction-related conditions to uncover both shared and disease-specific patterns. By integrating cross-disease protein associations with pathway-level analysis, it provides new insights into neuropsychiatric disease biology and highlights potential avenues for biomarker research and downstream validation.
What you'll learn:
-
How the breadth, strength, and direction of proteomic associations differ across neuropsychiatric conditions
-
Which protein signals recur across diseases, and which appear more disease-specific
-
How cross-disease analysis reveals that the same protein can show different association directions across disorders
-
How pathway enrichment adds biological context to individual protein associations
-
How these complementary insights can support hypothesis generation, candidate prioritization, and downstream validation
Explore UK Biobank insights into the proteome of neuropsychiatric diseases
